Korean
Korean

About Us

Letter from the CEO Business Overview Business History Core Networks C.I Introduction
Business Overview
HOME >  About us >  Letter from the CEO

Focusing on chronic intractable age-related diseases

“A Next-Generation Botanical Drug Platform Company”

- AI-based virtual human body system

Vision

“A Next-Generation New Botanical Drug Platform No.1 Corporation”

Business Area

New drug

  • Partnering & Licensing
  • Identification, Isolation, and Synthetic Derivatization of Active Ingredients
    → NCE Hits & Seeds

Functional food ingredient

  • Functional Food IngredPremiumients with Pharmaceutical Standards
  • Collaborative Commercialization & Stable Revenue Stream
Platform Technology
Infrastructure

CMC